Overview

Update
IPO / Stock
Went Public on Apr 10, 2014 / NASDAQ:CERU
Total Equity Funding
$85.7M in 8 Rounds from 7 Investors
Headquarters:
Cambridge, MA
Description:
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Founders:
,
Categories:
Therapeutics, Health Care, Nanotechnology
Website:
http://www.ceruleanrx.com
Social:

Company Details

Update

Cerulean Pharma Inc. is a privately-held biopharmaceutical company focused on the development of novel nanotechnology-based therapeutics in the areas of oncology, cardiovascular, autoimmune and inflammatory diseases.

The Company has assembled a world-class management team, board of directors and scientific advisory board that collectively have a significant track record of business building, product development and scientific breakthroughs from companies and institutions such as Cubist, GlaxoSmithKline, Merck, Millennium Pharmaceuticals, Inc., Pfizer, Wyeth, the Massachusetts Institute of Technology, Harvard Medical School, MD Anderson, Fox Chase Cancer Center and the Arizona Health Center.

Funding Rounds (11) - $151.7M

Update
DateAmount / RoundValuationLead InvestorInvestors
Apr, 2015$35M / Post Ipo Equity0
Jan, 2015$26M / Debt Financing0
Dec, 2012$13M / Private Equity0
Dec, 2011$15M / Series D6
Nov, 2010$24M / Series C5
Oct, 2010$1.5M / Venture0
Jun, 2010$5M / Debt Financing0
Jul, 2009$10M / Series B4
Jan, 2008$8.1M / Series B5
May, 2007$12.1M / Series A3
Dec, 2006$2M / Venture1

Current Team (8)

Update

Offices/Locations (1)

Update
  • Headquarters

    161 First Street

    Cambridge, MA 02142

    USA

Past Team (2)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos